Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicotinamide for Early Onset Preeclampsia
NCT02213094Phase 1Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Jan 2014
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of nicotinamide in preeclampsia (2 arms), sponsored by University of North Carolina at Chapel Hill. Primary endpoint: Number of Participants With Adverse Events at 48 hours. Started Jan 2014; status: completed.
02
Drugs
nicotinamide
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT02213094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02213094.